Vol.68 No.S-1 November 2020

An overview of oral lascufloxacin, a novel quinolone antibiotic

Kazuhiro Tateda, Sayoko Tanioka, Kyoichi Totsuka and Shigeru Kohno

Jpn. J. Chemother. 68 (S-1): 1-15, 2020

Pharmacokinetics of lascufloxacin in patients with renal dysfunction

Tetsuro Matsumoto, Toru Ikeda, Kazuya Kawahara, Hiroyuki Fukase and Yuto Ishihara

Jpn. J. Chemother. 68 (S-1): 16-23, 2020

Pharmacokinetics of lascufloxacin in patients with hepatic impairment

Takeshi Okanoue, Toshihide Shima, Fumiko Minami, Saiyu Tanaka, Shiro Takami and Shigeru Manita

Jpn. J. Chemother. 68 (S-1): 24-31, 2020

Effect of lascufloxacin on the plasma concentrations of theophylline in healthy volunteers

Yoshihito Niki, Takehiko Sanbe, Noriko Hida, Shigeru Manita and Naoki Uchida

Jpn. J. Chemother. 68 (S-1): 32-40, 2020

Phase III double-blind comparative study of lascufloxacin versus levofloxacin in patients with community-acquired pneumonia

Makoto Miki, Keiichi Mikasa, Junichi Kadota, Hiroshi Mukae, Jiro Fujita, Seiji Hori, Katsunori Yanagihara, Kazuhiro Tateda, Kyoichi Totsuka, Yasuko Umemoto and Shigeru Kohno

Jpn. J. Chemother. 68 (S-1): 41-54, 2020

Open-label study of lascufloxacin for secondary infections in patients with chronic pulmonary diseases and patients with acute bronchitis

Makoto Miki, Keiichi Mikasa, Junichi Kadota, Hiroshi Mukae, Jiro Fujita, Seiji Hori, Katsunori Yanagihara, Kazuhiro Tateda, Kyoichi Totsuka, Tomohiko Eiraku and Shigeru Kohno

Jpn. J. Chemother. 68 (S-1): 55-67, 2020

Phase III double-blind comparative study of lascufloxacin versus levofloxacin in patients with sinusitis

Yuichi Kurono, Hideyuki Kawauchi, Seiji Hori, Kazuhiro Tateda, Kyoichi Totsuka, Megumi Asano and Kenji Suzuki

Jpn. J. Chemother. 68 (S-1): 68-80, 2020

Open-label study of lascufloxacin in patients with otorhinolaryngological infections -Efficacy, Safety and Tissue Penetration-

Hideyuki Kawauchi, Yuichi Kurono, Seiji Hori, Kazuhiro Tateda, Kyoichi Totsuka, Masaaki Odajima and Kenji Suzuki

Jpn. J. Chemother. 68 (S-1): 81-95, 2020

Population pharmacokinetics and pharmacodynamics of oral lascufloxacin in patients with respiratory tract and otorhinolaryngological infections

Kyoichi Totsuka, Junichi Takano and Yuichi Masuda

Jpn. J. Chemother. 68 (S-1): 96-108, 2020